Clinical Trials
9
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Osteosarcoma Maintenance Therapy With OST31-164
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- George Clinical Pty Ltd
- Target Recruit Count
- 39
- Registration Number
- NCT04974008
- Locations
- 🇺🇸
Kaiser Permanente Downey Medical Center, Los Angeles, California, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
🇺🇸Rady Children's Hospital, San Diego, California, United States
Dapagliflozin Treatment in Type 2 Diabetes
- Conditions
- Impaired Renal FunctionDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2020-11-09
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- George Clinical Pty Ltd
- Target Recruit Count
- 17
- Registration Number
- NCT04620590
- Locations
- 🇺🇸
CU Anschutz Medical Campus - Clinical Translational Research Center (CTRC), Aurora, Colorado, United States
🇨🇦David Cherney, CM, PhD, Toronto, Ontario, Canada
Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension
- Conditions
- Treatment Resistant Hypertension
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- George Clinical Pty Ltd
- Target Recruit Count
- 1500
- Registration Number
- NCT03078244
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
- First Posted Date
- 2013-01-03
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- George Clinical Pty Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT01759303
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸Massachusetts General Hospital/Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
- First Posted Date
- 2011-04-07
- Last Posted Date
- 2023-03-10
- Lead Sponsor
- George Clinical Pty Ltd
- Target Recruit Count
- 47
- Registration Number
- NCT01330966
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸Edward Cancer Center, Naperville, Illinois, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States